Schulman Brett

CEO Schulman buys 150 CAVA shares at $48.98; stock down -67.7% from 52-wk high, down -23.0% in 30 days

Schulman, as CEO and President, purchased 150 shares at $48.98 on 2025-11-12, establishing his first stake at this company. The purchase occurs amid significant recent price deterioration: CAVA is trading down -67.7% from its 52-week high of $150.88 and down -23.0% over the past 30 days. Historically, Schulman's prior 5 trades at CAVA were all sells, with a 100% well-timed rate at the 90-day mark (negative 90-day returns in all cases). His cross-ticker track record shows 15 prior sells with a 66.67% well-timed rate over 90 days. The shift from repeated selling to a buy merits observation given the stock's severe drawdown, though the small 150-share position ($7.3K) limits visibility into any larger strategic shift.

CAVA CEO Schulman sold 327,000 shares for $49.1M on 2024-12-05; stock down 12.1% from 52-week high since

Brett Schulman, CEO and President, executed 4 separate sales totaling 327,000 shares for $49,069,620.00 at $150.06 on 2024-12-05, reducing his holdings by 28.7% from 1.14M to 811.1K shares. The current price of $132.57 sits 12.1% below the 52-week high of $150.88, meaning the stock has declined since the transaction executed near peak levels. His prior trades at CAVA show a timing pattern where 0 of 5 prior sells captured downside effectively—four of those five sells were followed by positive 90-day returns ranging from +14.1% to +39.2%, indicating prior sales occurred before subsequent rallies. The company shows strong fundamentals with 29.2% annual revenue growth, though the P/E of 602.59 reflects an extremely high valuation multiple typical of unprofitable or near-profitless growth companies.

CAVA CEO Schulman sells 201,504 shares for $25.3M at $125.53 avg, retains 716,090 shares post-sale

Brett Schulman, CAVA's CEO and President, executed 4 separate sales on 2024-08-26 totaling 201,504 shares for $25,294,557.20 at a blended average price of $125.53, reducing his holdings from 917,594 shares to 716,090 shares (a -22.0% reduction). The sales occurred near the company's 52-week high of $125.80, with the stock currently trading at $118.44 (-5.8% from that peak). Schulman's cross-ticker track record shows 1 prior sell with an average 30-day return of -6.5%; at CAVA specifically, his prior sell on 2024-06-14 also yielded a -6.5% 30-day return. The timing context is important: the company is growing revenue at +29.2% annually, yet carries an unusually elevated P/E ratio of 538.36, reflecting investor expectations that may leave limited margin for disappointment. The sale size—22% of pre-transaction holdings—represents a material reduction in CEO stake at a moment when valuation multiples are extreme relative to earnings power.

CEO Schulman sold 66.4K CAVA shares at $90.11 for $6.0M; stock now at 52-week high of $95.39.

CEO and President Brett Schulman sold 66,414 shares at $90.11 on 2024-06-14, reducing his holdings from 970,508 to 904,094 shares. The sale occurred when CAVA was trading modestly below its current price of $95.39, which marks the 52-week high. The company has demonstrated strong fundamental momentum with annual revenue growth of +29.2%, and the stock has appreciated +23.4% over the prior 30 days and +39.6% over 90 days. While the sale represents a 6.8% reduction in CEO holdings, the transaction occurred during a period of significant stock appreciation and near peak valuation levels, warranting investor attention to executive positioning relative to recent price momentum.